-
All Resources
(choose a category)
-
All Resources
-
selected
Evidence
Evidence, advice, guidance and standards
-
Improvement
Improvement and implementation support
-
Scrutiny
Assurance, scrutiny, measurement and reporting
-
-
Healthcare Area
- Blood and immune system
- Cancer
- Cardiovascular system
- Caring for older people
- Digestive system
- Ear, nose and throat
- Endocrine, nutritional and metabolic
- Eye
- Genitourinary system
- Health service organisation and delivery
- Infectious disease
- Injuries, accidents and wounds
- Mental and behavioural disorders
- Mouth and dental
- Musculoskeletal system
- Nervous system
- Obstetrics and gynaecology
- Paediatrics
- Public health
- Respiratory system
- Resource Type
- Programme
- Year
- prev
- Page 12 of 2
20 results found filtered by Evidence Remove Evidence Filter Digestive system Remove Digestive system Filter Clear Search
-
NICE STA Guidance 277 - Methylnaltrexone (Terminated Appraisal)
- Published
- 27 March 2013
- Cycle of Improvement
- Evidence
-
Gastric electrical stimulation (GES): Advice Statement 002-12
- Published
- 23 March 2012
- Cycle of Improvement
- Evidence
-
Gastric electrical stimulation: Technologies scoping report 5
- Published
- 23 March 2012
- Cycle of Improvement
- Evidence
-
Scottish Health Technologies Group Status Reports
- Published
- 18 January 2012
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 211 – Prucalopride for the treatment of chronic constipation in women
- Published
- 15 December 2010
- Cycle of Improvement
- Evidence
-
Evidence based assessment report 2010-003
- Published
- 29 July 2010
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 187 – Infliximab (review) and adalimumab for the treatment of Crohn’s disease
- Published
- 24 February 2010
- Cycle of Improvement
- Evidence
-
Evidence based assessment report 2009-003
- Published
- 18 August 2009
- Cycle of Improvement
- Evidence
-
Evidence based assessment report 2009-001
- Published
- 17 February 2009
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 163 – Infliximab for acute exacerbations of ulcerative colitis
- Published
- 17 December 2008
- Cycle of Improvement
- Evidence